PFE - Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis.

As of Jun 26, 2026: spot at $24.09, ATM IV 22.2%, max pain $25.00, net GEX -$33.3M.

Sector
Healthcare
Industry
Drug Manufacturers - General
Market Cap
$138.41B
P/E Ratio
18.45
Beta
0.29
52-Week Range
23.11-28.75
Dividend Yield
$1.72
CEO
Albert Bourla
Employees
81,000
IPO Date
Jun 1, 1972
Exchange
NYSE

What PFE Looks Like to Options Traders Today

IV rank of 27.3% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$33.3M) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (-0.004) is roughly flat across the wings.

What This Page Covers

The PFE overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.

Frequently asked PFE overview questions

What is PFE?
PFE is the ticker symbol for Pfizer Inc., a listed security. Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Listed on NYSE. PFE is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
What does the PFE options snapshot look like today?
As of Jun 26, 2026, the PFE options snapshot shows spot at $24.09, ATM IV 22.2%, IV rank 27.3%, max pain $25.00, net GEX -$33.3M, expected move 6.37%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
What are PFE's key statistics?
Pfizer Inc. (PFE) carries a market capitalization of $138.41B, trailing P/E ratio of 18.45, beta of 0.29 relative to the broader market, 52-week range of 23.11-28.75. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
What sector or industry does PFE belong to?
Pfizer Inc. operates in the Healthcare sector, in the Drug Manufacturers - General industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare PFE's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
How current is the PFE data on this page?
The options snapshot above is dated Jun 26, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).